Home Medizin RA-Ergebnisse werden durch Depression und Angst verschlechtert

RA-Ergebnisse werden durch Depression und Angst verschlechtert

von NFI Redaktion

A new study presented at the Canadian Rheumatology Association’s 2024 Annual Meeting in Winnipeg, Manitoba, Canada, found that patients with rheumatoid arthritis (RA) who also have comorbid anxiety or depression are less likely to achieve low disease activity (LDA) and better symptom control after three months of treatment. Susan Bartlett, PhD, Professor of Clinical Epidemiology, Rheumatology, and Respiratory Epidemiology at McGill University in Montreal, Quebec, Canada, highlighted the importance of a multidisciplinary approach in the treatment of RA.

The study, presented by Bartlett on February 29, examined the impact of specific symptom clusters on the prognosis of RA. Symptom clusters are groups of related symptoms that occur together and may have worse consequences than individual symptoms alone. The study analyzed data from the Canadian Early Arthritis Cohort (CATCH) study and identified four main symptom clusters in RA patients: minimal symptoms, mild physical and emotional symptoms, moderate to severe pain and fatigue, and moderate to severe physical and emotional symptoms.

Patients with moderate to severe emotional symptoms had a worse prognosis, with a lower likelihood of experiencing milder symptoms compared to those with only pain and fatigue or mild emotional symptoms. The study emphasized the importance of addressing anxiety and depression, as they are important markers that can impact treatment outcomes.

Another related study conducted at the Ottawa Hospital in Ontario, Canada, examined how depression in RA patients affected subjective and objective measures of the disease. The researchers found that patients with depression reported higher subjective disease measurements but did not show significant differences in objective disease measures compared to those without depression. The study highlighted the need to address depression as a comorbidity that can impact treatment outcomes in RA patients.

Both studies underscored the importance of addressing the emotional aspect of RA in treatment plans to improve patient outcomes. A comprehensive approach that includes addressing depression is essential to help patients achieve remission and better disease control. The results from both studies corroborated each other’s findings, emphasizing the need to consider the emotional well-being of RA patients in treatment strategies.

Related Posts

Adblock Detected

Please support us by disabling your AdBlocker extension from your browsers for our website.